These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15332694)

  • 1. Pharmacist surveillance of adverse drug events.
    Forster AJ; Halil RB; Tierney MG
    Am J Health Syst Pharm; 2004 Jul; 61(14):1466-72. PubMed ID: 15332694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
    Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
    Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
    Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
    BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study.
    Sakuma M; Ida H; Nakamura T; Ohta Y; Yamamoto K; Seki S; Hiroi K; Kikuchi K; Nakayama K; Bates DW; Morimoto T
    BMJ Qual Saf; 2014 Oct; 23(10):830-7. PubMed ID: 24742779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.
    Carayon P; Wetterneck TB; Cartmill R; Blosky MA; Brown R; Kim R; Kukreja S; Johnson M; Paris B; Wood KE; Walker J
    BMJ Qual Saf; 2014 Jan; 23(1):56-65. PubMed ID: 24050986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
    Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
    BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication errors and adverse drug events in pediatric inpatients.
    Kaushal R; Bates DW; Landrigan C; McKenna KJ; Clapp MD; Federico F; Goldmann DA
    JAMA; 2001 Apr; 285(16):2114-20. PubMed ID: 11311101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug events and medication errors in Australia.
    Runciman WB; Roughead EE; Semple SJ; Adams RJ
    Int J Qual Health Care; 2003 Dec; 15 Suppl 1():i49-59. PubMed ID: 14660523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical approach to determining costs and frequency of adverse drug events in a health care network.
    Senst BL; Achusim LE; Genest RP; Cosentino LA; Ford CC; Little JA; Raybon SJ; Bates DW
    Am J Health Syst Pharm; 2001 Jun; 58(12):1126-32. PubMed ID: 11449856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
    Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
    J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.
    Kuklik N; Stausberg J; Amiri M; Jöckel KH
    BMC Health Serv Res; 2019 Aug; 19(1):555. PubMed ID: 31395053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
    Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
    Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
    Chen CC; Hsiao FY; Shen LJ; Wu CC
    Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients.
    Díaz Hernández SH; Cruz-Gonzalez I
    Consult Pharm; 2018 Aug; 33(8):454-466. PubMed ID: 30068439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.
    Overhage JM; Gandhi TK; Hope C; Seger AC; Murray MD; Orav EJ; Bates DW
    J Patient Saf; 2016 Jun; 12(2):69-74. PubMed ID: 26001546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.